Nicotinic acetylcholinergic receptors (nAChR's) have been implicated in several brain disorders, including addiction, Parkinson's disease, Alzheimer's disease and schizophrenia. Here we report in vitro selectivity and functional properties, toxicity in rats, in vivo evaluation in humans, and comparison across species of [ 18 F]Nifene, a fast acting PET imaging agent for a4b2* nAChRs. Nifene had subnanomolar affinities for ha2b2 (0.34 nM), ha3b2 (0.80 nM) and ha4b2 (0.83 nM) nAChR but weaker (27-219 nM) for hb4 nAChR subtypes and 169 nM for ha7 nAChR. In functional assays, Nifene (100 lM) exhibited 14% agonist and >50% antagonist characteristics. In 14-day acute toxicity in rats, the maximum tolerated dose (MTD) and the no observed adverse effect level 
of human PET studies have been obtained using [ 18 F]2-FA85380 (e.g., Sultzer et al., 2017) . However, subject compliance due to the long scan times (up to 6 hr) of the radioligand has been a concern for human studies (Brody et al., 2009) . Therefore, newer PET imaging agents are now being suggested for studies of the elderly and challenged subjects (Declercq, Vandenberghe, Von Laere, Verbruggen, & Bormans 2016) .
New PET radioligands such as [ XTRA with faster brain kinetics for a4b2* receptors have been evaluated in humans (e.g., Sabri et al., 2015; Kuwabara et al., 2016) .
Technical capability of using a radioligand with faster in vivo kinetics for imaging a4b2* receptors has been developed in our laboratory. Our tracer design included the pyridinylether backbone which led to the successful development of novel radiotracer [ Lao et al., 2017) . A shorter scan time is important for several reasons: (1) Patient comfort, especially when the scans are to be carried out on the elderly and ailing population and thus improve subject compliance; (2) Motion artifacts, which often accompany scans and are critical with higher resolution scanners; and (3) Scanner time, due to increased volume of PET studies, scanner time is limited. Compared to existing agents (Kuwabara et al., 2016) , [ 18 F]Nifene has shown to be superior in terms of imaging times in all species, providing reasonable target-to-nontarget ratios and providing the ability to visualize extrathalamic receptors .
Ligand binding site of the a4b2* nAChR across the various species is highly conserved (Albuquerque, Pereira, Alkondon, & Rogers, 2009) , suggesting a high degree of similarity in receptor-ligand interaction.
However, brain distribution of the a4b2* nAChR has been known to vary across species as shown by the mRNA localization of a2, a3, a4, and b2 subunits in rat (Wada et al., 1989) and monkey brain (Han et al., 2000) . Our previously reported biological properties of [ 18 
F]
Nifene in rodents (Kant et al., 2011; Bieszczad et al., 2012) , monkeys (Pichika et al., 2006; Hillmer et al., 2011 Hillmer et al., , 2013 , and humans ) suggest some regional variations of binding of [ These have been studied by high-field MRI (Cho et al., 2015) , and shown to be responsive to nicotine using diffusion tensor imaging (DTI) (Kochunov et al., 2013) ; (6) Aging effects on [ 
| M E TH ODS

| General Methods
Nifene and 2-nitronifene precursor were prepared in house using reported methods (>95% purity, Pichika et al., 2006) 
| Radiopharmaceutical
The radiosynthesis of [ ]fluoride in an automated synthesizer followed by deprotection using previously described procedures for the various species (Pichika et al., 2006; Hillmer et al., 2011 compound tested at receptor subtypes. Significant inhibition was considered > 50% at a 10 lM Nifene concentration at the different receptor sites. In vitro affinity studies of Nifene to a4b2* nAChR in rat brain homogenates (Pichika et al., 2006) and rat brain slices were previously reported using [ 3 H]cytisine (Easwaramoorthy et al., 2007) . .
| Functional Assays
| Image analysis
The PMOD software was used to normalize rat PET images to the standard space described by the stereotaxic coordinates (Paxinos & Watson, 2006) Mouse PET images were coregistered to a MRI mouse brain template (Ma et al., 2005; Constantinescu et al., 2013) (Logan et al., 1996) . Nondisplaceable binding potential (BP ND ) was calculated as "DVR-1" (further details described in Kant et al., 2011) . 
| R E SU LTS
| 18 F-Nifene Synthesis
The radiosynthesis of [ 
| In Vitro Binding Selectivity
Nifene exhibited subnanomolar affinities for the ha2b2 (0.34 nM), ha3b2 (0.80 nM) and ha4b2 (0.83 nM) nAChR and were approximately an order of magnitude better than those measured for nicotine ( Figure 2 ). For the hb4 nAChR subtypes, the affinities of both Nifene and nicotine were similar and in the range of 27-219 nM with a potency order of ha4b4> ha2b4> ha4b4 for both Nifene and nicotine ( Figure 3 ). Nifene exhibited weak affinity (169 nM) for the ha7 nAChR ( Table 1) . Affinity of Nifene and nicotine for rat brain b2 nAChR measured using [ 3 H]cytisine were similar to affinities for the human b2
nAChR. For all other receptor subtypes tested, Nifene did not exhibit significant affinity at 10 lM concentration.
| Functional Properties
In comparison to 100% agonist activity ([ 
| Human PET Studies
As reported by Lao et al. (2017) , [ for females and 1.56 for males, and may be reflective of a2b2 binding based on nonhuman primate observations of exclusive a2 subunits in the red nucleus (Han et al., 2000; Zoli, Pistillo, & Gotti, 2015) . (Savitz et al., 2011) , and may be difficult to accurately assess using the resolution of human HR1 PET scanner 
| Thalamocortical Radiations
At least four types of thalamocortical radiations were observed with 
| Aging Effects
Age and gender of all the subjects and the distribution volume ratios (DVR) in brain regions are summarized in Table 3 . Age spanned 5 decades in both male and female subjects. Thalamus exhibited the highest DVR values in both the genders with no significant change with aging.
Similarly, in other brain regions, lateral geniculate and SN/VTA also did not exhibit any age-related effects. Greater variation were found in the DVR values of frontal cortex and cerebellum (showing an increase with age), however, significance of this will require a larger number of subjects.
| Gender Effects
There were significant differences between male and female in the various brain regions. Female subjects showed higher DVR values compared to males in all the brain regions that were evaluated. In the thalamus, females had an average DVR of 2.58 6 0.11 while males had 2.24 6 0.10, which is 15% higher in females compared to males (pvalue of 0.004). Similarly, in LG, females had an average DVR of 2.46 6 0.07 while males had 2.17 6 0.08, which is 13% higher in females compared to males (p-value of 0.001). Substantia nigra/VTA showed a DVR 
| D I SCUSSION
Nifene was designed to be structurally similar to nicotine, containing the pyridine ring and the 5-membered unsaturated 3,4-dehydropyrrolidine In human nAChR clones, overall affinity of Nifene was found to be higher than nicotine as summarized in Table 1 . Nifene was found to have high affinity for the three hb2 nAChR subtypes (a2>a3a4).
FIG URE 4 Pituitary and Olfactory Human [ 18 F]Nifene PET: (a-c). Sagittal brain slices (a: MR; b: PET and c: PET/MR) showing [ 18 F]Nifene (DVR) in the pituitary gland (Pit). (d). Coregistered PET/MRI of transaxial brain slice showing olfactory gyri (OG), temporal cortex (TC), pons and cerebellum (CB). (e-h). Sequential close up (x2) slices of OG showing distinct [
Our previous studies with [ show subunit concentration levels: b2>a4>a3>a2, of which a4b2 nAChR being the major subtype (Wada et al., 1989) . In the nonhuman primate however, the order is b2>a4>a2>a3, with significantly higher levels of a2 compared to rats (Han et al., 2000) . Interestingly, it must be noted that while Nifene had an order of magnitude better affinity for the hb2 nAChR subtypes compared to nicotine, their affinities for the hb4 nAChR subtypes were similar.
In functional assays, compared to nicotine, Nifene was found to exhibit greater antagonist properties at 100 lM concentrations compared to agonist properties ( Table 2 ). The small difference in structure between nicotine and Nifene ( Figure 1 ) causes a dramatic change in their functional properties. Previous reports on pyridylether derivatives have shown a change from agonist to antagonist character when substituent groups, such as a propyl or butyl group are included at the 5-position of the pyridine ring (Lin et al, 1998 ). This structure-activity relationship was considered when we designed the fluoroalkyl derivatives as putative antagonists (Chattopadhyay et al., 2005; Pichika et al., 2013 ). Our findings with Nifene which has a small fluorine atom at the 2-position in the pyridine ring without a fluoropropyl group was unexpected. The large electronic effects of fluorine, both spatial and inductive, may be causing a shift in its functional properties. Thus, Nifene may be characterized as a partial agonist. It should be noted that varencline, the smoking cessation drug is also known to be a partial agonist and has 30-60% in vivo efficacy compared to nicotine (Niaura, Jones, & Kirkpatrick, 2006 effects in mice at >3 lmol/kg (or >0.5 mg/kg) which is significantly greater than doses used in PET studies (Vaupel et al., 2005) . There were no adverse effects with [ (Table 3 ). The hypothalamus-pituitary-adrenal (HPA) axis has been known to be involved in various physiological responses, including stress, mood disorders, and others (Bertrand, 2005) . The HPA axis is stimulated by nicotine and smoking resulting in the increase of ACTH and cortisol (Tweed, Hsia, Lufty, & Friedman, 2012) . Interaction of nicotine at the nAChRs both in the hypothalamus and pituitary as well as other brain regions may be involved in this endocrine effect (Zemkova, Kucka, Bjelobaba, Tomic, & Stojilkovic, 2013) .
The habenula has been shown to play a role in nicotine withdrawal signs and other properties of nicotine (Baldwin, Alanis, & Salas, 2011) .
In the nonhuman primate, mRNA for the a3 subtype (both a3b4 and a3b2) have been found in greater amounts compared to other subtypes in the habenula (Han et al, 2000) . Affinity of Nifene for the a3b4 subtype is 190 nM, and with this weak affinity it is unlikely [ Additionally, because of the spillover effects from the SN/VTA, the measurement may be further confounded. It has been postulated that antagonists for a3b4 acting on the habenula may have a role in smoking cessation (Harrington et al., 2016) . It must be noted that Nifene has a >50% antagonist character for the a3b4 subtype (Table 2) .
Since Nifene showed the highest affinity for the a2b2 subtype, brain regions with potentially significant levels of this subtype were examined. Although human postmortem data is not available on the distribution of this receptor subtype, information from the rodent models suggest at least two prominent areas, IPN and olfactory bulb which may contain higher a2 receptor levels (Whiteaker et al., 2009) fold higher affinity for a2b2 compared to a3b2 and a4b2 subtypes, it may be necessary to enhance this selectivity in favor of a2b2 in order to more clearly identify brain regions containing this receptor subtype.
The increasing significance of the a2b2 subtype suggests a need for a more selective PET radiotracer for this receptor subtype.
Nicotinic acetylcholinergic receptors have now been shown to play a critical role in brain connectivity through nonsynaptic transmission (Lendvai & Sylvester, 2008) . In a preliminary study, the binding of a PET radiotracer to the human brain white matter was observed (Ding et al., 2004) . Recent studies on the effect of nicotine using DTI have found activation of several white matter tracts further suggesting a CNS role of non-neuronal nicotinic receptors (Kochunov et al., 2013; Yu et al., 2016) . Thalamocortical radiations in the white matter tracts have been reported to play a critical role in brain injury (Thomas et al., 2005) and motor and verbal memory (Philip, Korgaonkar, & Grieve, 2014 (Kochunov et al., 2013) , in adolescent/ young adult smokers (Gogliettino, Potenza, & Yip, 2016) , and lesions smokers in clinically isolated syndrome, a demyelinating disorder, a precursor to multiple sclerosis (Durhan et al., 2016) . Inferior thalamic radiations (ITR) project to the temporal cortex including auditory cortex where auditory projections from medial geniculate nucleus have been studied using fMRI and diffusion tractography (Javed et al., 2014 There have been few animal studies on the effects of aging on a4b2* nAChRs. A detailed autoradiographic study in rats (2-month old vs. 20-month old) did not find a change in nAChR (Tribollet, Bertrand, Marguerat, & Raggenbass, 2004) . Other mice studies have shown either no change or a small decrease in receptor concentrations in select brain regions with aging (Rogers, Gahring, Collins, & Marks, 1998; Ferrari, Pedrazzi, Algeri, Agnati, & Zoli, 1999; Picciotto & Zoli, 2002) . Postmortem human brain studies revealed an age-related reduction in the binding of (6)-[ 3 H]epibatidine in frontal and temporal cortex (Marutle et al., 1998) . Aging effects in human PET studies of this receptor using [ These studies indicate that the loss of D2/D3 receptors may be approximately 6-13% per decade (Mukherjee et al., 2002) . Using our previously published data on D2/D3 receptors on a separate group of subjects (Mukherjee et al., 2002) , both thalamus and substantia nigra/ ventral tegmental area show a decline with aging ( Figure 8b ), whereas a4b2* nAChR in the present study do not exhibit any significant change due to aging in these regions. The selective sparing of a4b2* nAChR is noteworthy, since it has been suggested that the loss of D2/ D3 receptors may be from degeneration of neurons due to progressive free radical damage to cells, loss of proteins due to inefficient recycling, decrease in D2 receptor gene transcription, cell death, etc. (Semsei, 2000; Tohgi, Utsugisawa, Yoshimura, Nagane, & Mihara 1998 This finding is consistent with the higher binding of [ and in a PET study using [
18 F]2-FA-85380 (Meyer et al., 2009) . A faster brain nicotine accumulation has been reported in the case of females versus males (Zuo et al., 2015) and higher activation of brain regions to smoking cues in females has also been observed (Zanchi, Brody, Borgwardt, & Haller, 2016) . Since females have a greater neuropharmacological response to nicotine compared to males (references cited in Zuo et al., 2015) , it remains to be seen if the higher DVR in females is a contributing factor to the female-male differences, including the higher relapse seen in females (e.g., Xu et al., 2008 The binding affinity of Nifene was similar in rat and human (Table   1 ). [ lum was an exception which showed higher binding while corpus callosum was the least . In our rat studies, amongst the white matter regions investigated, corpus callosum had the least amount of [ 18 F]Nifene binding (Bieszczad et al., 2012) . As seen in Figure 
